tiprankstipranks
Trending News
More News >
Myriad Genetics (MYGN)
NASDAQ:MYGN

Myriad Genetics (MYGN) Revenue

Compare
392 Followers

Myriad Genetics Revenue

Myriad Genetics had a revenue of 195.90M in the quarter ending Mar 31, 2025, with -6.98%. This bring the company's revenue in the last twelve months to 831.30M, Increased -0.75%. In the fiscal year ending Dec 31, 2024, Myriad Genetics had annual revenue of 837.60M with 11.21% growth.
Revenue (ttm)
831.30M
Revenue Growth
7.38%
P/S Ratio
0.61
Revenue/Employee
$310,222
Employees
2,700
Market Cap
$509.74M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
837.60M84.40M+11.21%
Dec 31, 2023
753.20M74.80M+11.03%
Dec 31, 2022
678.40M-12.20M-1.77%
Dec 31, 2021
690.60M133.60M+23.99%
Dec 31, 2020
557.00M-81.60M-12.78%
Jun 30, 2020
638.60M-212.50M-24.97%
Jun 30, 2019
851.10M78.50M+10.16%
Jun 30, 2018
772.60M1.20M+0.16%
Jun 30, 2017
771.40M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis